Tactile Systems Technology Inc (NASDAQ:TCMD) COO Robert J. Folkes sold 5,000 shares of Tactile Systems Technology stock in a transaction on Thursday, March 14th. The stock was sold at an average price of $66.04, for a total transaction of $330,200.00. Following the sale, the chief operating officer now owns 111,654 shares of the company’s stock, valued at $7,373,630.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Shares of NASDAQ:TCMD traded up $0.26 on Friday, hitting $63.19. 427,200 shares of the company were exchanged, compared to its average volume of 274,320. Tactile Systems Technology Inc has a 1-year low of $30.21 and a 1-year high of $76.63. The company has a market capitalization of $1.18 billion, a P/E ratio of 225.68, a PEG ratio of 10.02 and a beta of 2.36.
Several equities research analysts have recently commented on TCMD shares. BidaskClub downgraded shares of Tactile Systems Technology from a “buy” rating to a “hold” rating in a research note on Wednesday, November 21st. ValuEngine downgraded shares of Tactile Systems Technology from a “buy” rating to a “hold” rating in a research note on Friday, December 7th. Northland Securities upgraded shares of Tactile Systems Technology from an “under perform” rating to a “market perform” rating in a research note on Wednesday, January 2nd. Piper Jaffray Companies lifted their price objective on shares of Tactile Systems Technology to $80.00 and gave the stock a “positive” rating in a research note on Monday, January 7th. Finally, Zacks Investment Research downgraded shares of Tactile Systems Technology from a “buy” rating to a “hold” rating in a research note on Thursday, January 10th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Tactile Systems Technology currently has a consensus rating of “Buy” and a consensus price target of $70.00.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices for the treatment of chronic diseases in the United States. The company offers proprietary Flexitouch system, an at-home solution for lymphedema patients; and ACTitouch system, a home-based solution for chronic venous insufficiency patients.
Read More: Asset Allocation
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.